“Characteristics of Patients With a Complete Response Treated With Dabrafenib + Trametinib Combination Therapy: Findings From Pooled COMBI-d and COMBI-v 5-Year Analysis”, J of Skin, vol. 4, no. 6, p. s112, Oct. 2020, doi: 10.25251/skin.4.supp.112.